Absci (ABSI) Treasury Shares (2020 - 2021)
Absci (ABSI) posted Treasury Shares of $5.0 million for Q1 2026, up 32.32% sequentially from $3.8 million in Q4 2025, and up 14.36% YoY from $4.4 million in Q1 2025.
Analysis
Absci (ABSI) Treasury Shares (2020 - 2021) Analysis & Trends
Absci has reported Treasury Shares for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Treasury Shares rose 14.36% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 14.36% YoY) and the FY2025 annual result came in at $3.8 million, up 2.1% from the prior year.
- Treasury Shares improved to $5.0 million in Q1 2026 per ABSI's latest filing, from $3.8 million in the prior quarter.
- Over five years, Treasury Shares peaked at $5.0 million in Q1 2026 and troughed at $394736.0 in Q3 2023.
- A 5-year average of $2.5 million and a median of $2.2 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares sank 76.64% in 2023, then soared 1015.43% in 2025.
- Over 5 years, Treasury Shares stood at $1.0 million in 2022, then jumped by 116.95% to $2.2 million in 2023, then soared by 68.84% to $3.7 million in 2024, then grew by 2.1% to $3.8 million in 2025, then jumped by 32.32% to $5.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $5.0 million, $3.8 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 14.01 Mn |
| Jun 30, 2021 | 14.01 Mn |
| Mar 31, 2021 | 14.01 Mn |
| Mar 31, 2021 | 14.01 Mn |
| Dec 31, 2020 | 13.75 Mn |
| Dec 31, 2020 | 13.75 Mn |
| Sep 30, 2020 | 10.44 Mn |
| Sep 30, 2020 | 10.44 Mn |
| Jun 30, 2020 | 10.44 Mn |
| Jun 30, 2020 | 10.44 Mn |